AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Mesalamine
6 registrations across 3 African markets— 6 active
Markets with Mesalamine
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MELANEZ SUPPOSITORY | 🇬🇭Ghana | — | active | Jan 2030 |
| MELANEZ SUPPOSITORY | 🇬🇭Ghana | — | active | Jan 2030 |
| COLISTICOL 1200 Tablet | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD. | active | Sept 2029 |
| MESAMIN OD 800MG Prolonged-Release Tablet | 🇰🇪Kenya | CLINIGEN KENYA (PLC) LTD | active | Nov 2028 |
| MESAMIN OD 1.2 GM Prolonged-Release Tablet | 🇰🇪Kenya | CLINIGEN KENYA (PLC) LTD | active | Apr 2028 |
| COLIMEND 1.2 g Tablets | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
Mesalamine in Africa — Regulatory Overview
Mesalamine is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Ghana, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.